$REGN Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of $20.07 up 69.65% YoY
• Reported revenue of $5.12B up 36.27% YoY
• Regenerons updated 2026 guidance includes GAAP and non-GAAP gross margin on net product sales of approximately 80% and 86%, respectively, and GAAP R&D of $6.6B and non-GAAP R&D of $6.05B.